International Journal of Molecular Sciences, Volume 24, Issue 13
2023 July-1 - 820 articles
Cover Story: Hepatocellular carcinoma (HCC) is often diagnosed at an unresectable advanced stage. Advanced HCC is treated with systemic chemotherapy as well as transarterial chemoembolization and hepatic transarterial infusion chemotherapy with cisplatin, which have long been the standard of care for patients with unresectable HCC, but have been limited to the treatment of intrahepatic disease. Recently, systemic chemotherapy with molecularly targeted agents and immune checkpoint inhibitors has been reported to be effective in treating unresectable HCC, and the treatment of unresectable HCC has undergone a major paradigm shift. This review summarizes the action and resistance mechanisms of cisplatin and describes the treatment of major hepatobiliary cancers with cisplatin. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.